The 5 analysts offering 12-month price forecasts for Itamar Medical Ltd have a median target of 31.00, with a high estimate of 33.85 and a low estimate of 31.00. The median estimate represents a +2.38% increase from the last price of 30.28.
The current consensus among 5 polled investment analysts is to Hold stock in Itamar Medical Ltd. This rating has held steady since September, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.18
Reporting Date Nov 30
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.